Colombia regulator approves Pfizer-BioNTech vaccine for emergency use - (Fidelity via NewsPoints Desk)

  • Colombia's drug regulator has authorized emergency use of Pfizer and BioNTech's COVID-19 vaccine, as reported in Fidelity.

  • The country now awaits approval for vaccines produced by AstraZeneca and Johnson & Johnson, noted President Ivan Duque.

  • According to the news source, patients aged 60 and over, or with co-morbidities such as asthma and diabetes, will be among the first in line for vaccines, as well as health workers.

  • Colombia has reached deals to buy 10 million doses each of the Pfizer/BioNTech and AstraZeneca vaccines, as well as 9 million from Johnson & Johnson. The country has also secured 20 million vaccine doses via the World Health Organization-backed COVAX mechanism.

  • Colombia will receive its first delivery of 1.7 million Pfizer/BioNTech vaccine doses in February, with vaccinations beginning immediately, according to the minister of health.

To read more NewsPoints articles, click here.